Sentences with phrase «human embryonic stem cell treatment»

Federal officials have approved the start of human embryonic stem cell treatment experiments on patients suffering a leading cause of vision loss.

Not exact matches

The truth, of course, is that there are no human embryonic stem - cell therapies even in clinical trial, let alone ready for therapy, and there have been no major treatment....

research; since most of the reports have concentrated on justifying the creation of cloned human embryos for research into and treatment of neurodegenerative diseases such as Parkinson's, «stem - cells» has become synonymous with «embryonic stem - cells» in the public imagination.

Peter Tatchell, human rights campaigner, talked about Catholic dissent from the Pope's hardline, intolerant opposition to liberation theology, women's rights, gay equality, contraception, fertility treatment, embryonic stem cell research and the Pope's collusion with Holocaust deniers and appeasers.

Trials of cells made from human embryonic stem cells are also poised to begin in people with type 1 diabetes and heart failure, the first time embryonic stem cells have been used in the treatment of major lethal diseases.

Decades after they were discovered, human embryonic stem cells are being trialled as a treatment for two major diseases: heart failure and type 1 diabetes

«It's an exciting development, and we await the outcome over the next year to see how well these cells integrate, and if there are any potential adverse reactions,» says Mike Cheetham of the Institute of Ophthalmology at University College London, one site where research is under way into a human embryonic stem - cell treatment for AMD.

In the past year, the South Korean Food and Drug Administration (FDA) has approved the world's first three stem - cell treatments — Hearticellgram - AMI, Cupistem and Cartistem — which followed on the heels of clinical tests for human embryonic stem - cell therapies approved in 2010, according to the health ministry.

A person with spinal injuries today went down in history as the first to receive a treatment derived from human embryonic stem cells (hESCs).

One is using cells derived from human embryonic stem cells to treat spinal cord injury (although funding problems have stopped the trial enrolling new patients) and another is testing a treatment for age - related macular degeneration.

A trial in 18 people with damaged retinal cells is being hailed as the most promising yet for a treatment based on human embryonic stem cells (hESCs).

At present, there are no embryonic stem - cell treatments approved by the US Food and Drug Administration, and most human studies of such therapies have shown unremarkable results.

An eye implant made of a thin sheet of human embryonic stem cells could be considered as an effective treatment for a common form of vision loss.

Government regulators have given the go - ahead to a second study that will for the first time carefully test a treatment created using human embryonic stem cells in people, according to the company sponsoring the experiment.

Federal officials have cleared a second clinical trial of a human embryonic stem - cell treatment, a company announced Monday, for a progressive blindness syndrome affecting young people.

For the first time, an experimental treatment made from human embryonic stem cells has shown evidence of helping someone, partially restoring sight to two people suffering from slowly progressing forms of blindness

Frequently lost in the policy discussions about human embryonic stem cells research are concrete realities that will determine how quickly such research will result in treatments and cures.

The challenge takes on even more urgency with recent developments, including a federal administration now more open to exploring the potential of stem cells, the recent FDA approval of a human trial involving embryonic stem cells, as well as the reported case of a young boy who developed a brain tumor four years after receiving a stem - cell treatment for a rare genetic disorder.

Forbes, Robert Langreth, February 20, 2008: In progress toward a stem - cell treatment for diabetes, researchers at a small San Diego biotech company have devised a procedure for turning human embryonic stems cells into insulin - producing cells inside mice.

This experimental treatment for type 1 diabetes combines the Encaptra ™ drug delivery system, which is a semi-permeable pouch, and PEC - 01 ™ cells, pancreatic precursor cells derived from human embryonic stem cells.

Kadimastem's product, AstroRx ® is a human embryonic stem cell (hESC)- based treatment for amyotrophic lateral sclerosis (ALS), based on astrocytes produced from stem cells.

Human embryonic stem cells (hESCs) could serve as an expandable source for neurons production, which could be applied for the treatment of various diseases affecting brain.

It is a technology, which purpose is obtaining embryonic stem cells for research and use in the treatment of various human diseases.

Treatment of perianal fistulas with human embryonic stem cell - derived mesenchymal cells: a canine model of human fistualizing Crohn's disease.

Treatment of canine perianal fistulas with an intralesional injection of human mesenchymal, embryonic - derived stem cells (hE - MSCS), Annual Congress of the European Society of Veterinary Dermatology and European College of Veterinary Dermatology.

Treatment of canine perianal fistulas with an intralesional injection of human mesenchymal, embryonic - derived stem cells (hE - MSCs).